Availability of Benzathine Penicillin G for Syphilis Treatment in Shandong Province, Eastern China

Overview

Journal BMC Health Serv Res

Publisher Biomed Central

Specialty Health Services

Date 2019 Mar 24

PMID 30902053

Citations 5

Authors

Xinlong Chen

Guigang Li

Yanling Gan

Tongsheng Chu

Dianchang Liu

Affiliations

Soon will be listed here.

Abstract

Background: The shortage of benzathine penicillin G (BPG) worldwide presents a major challenge in the treatment of syphilis. Its availability for syphilis treatment has not been adequately evaluated in China.

Methods: Two surveys were conducted among hospitals providing sexually transmitted infection clinical services in Shandong Province in 2012 and 2018. Data on the basic information and BPG availability of the surveyed hospitals and related factors were collected and analyzed using SPSS 17.0.

Results: A total of 433 and 515 hospitals were surveyed in 2012 and 2018, respectively. A significant difference in BPG availability was observed among different levels and types of hospitals both in 2012 (X = 9.747, p = 0.008; X = 37.167, p = 0.000) and 2018 (X = 11.775, p = 0.003; X = 28.331, p = 0.000). The BPG availability among surveyed hospitals increased from 45.0% in 2012 to 56.4% in 2018 (X = 11.131, p = 0.001). The BPG availability was higher in 2018 than in 2012 among county-level hospitals (52.0% vs. 40.8%, X = 7.783, p = 0.005), general western medicine hospitals (62.1% vs. 50.0%, X = 6.742, p = 0.009), maternal and child health hospitals (57.1% vs. 26.9%, X = 13.906, p = 0.000), and public hospitals (56.8% vs. 45.0%, X = 11.361, p = 0.001). However, the county-level availability of BPG (at least one hospital has BPG in a county-level unit) has not improved between 2012 and 2018 (65.93% vs. 70.34%; X = 0.563, p = 0.453). The absences of clinical needs, restriction of clinical antibacterial drugs, and lack of qualifications for providing syphilis treatment were the major reasons for the low BPG availability of hospitals.

Conclusions: BPG availability for syphilis treatment in Shandong Province remains low and presents disparities among different levels and types of hospitals, although it has been improved in recent years. The low availability of BPG for syphilis treatment in China is related to its clinical use by doctors rather than the market supply. Health care reforms should further improve the availability and accessibility of health services.

Citing Articles

Benzathine Penicillin G Shortage and Secondary Syphilis.

Snider W, Depew I, Cook S, Roth D Cureus. 2024; 16(8):e66787.

PMID: 39268312 PMC: 11392051. DOI: 10.7759/cureus.66787.

Evaluating the effect of the plan of national syphilis control in controlling the syphilis epidemic in Jiangsu, China 2010-2020.

Shi L, Chen L, Liu X, Hu H, Chen Y, Chen Y Front Public Health. 2024; 11:1281229.

PMID: 38186690 PMC: 10768032. DOI: 10.3389/fpubh.2023.1281229.

Research of Combined ES-BP Model in Predicting Syphilis Incidence 1982-2020 in Mainland China.

Zhao D Iran J Public Health. 2023; 52(10):2063-2072.

PMID: 37899935 PMC: 10612558. DOI: 10.18502/ijph.v52i10.13844.

The Clinical Characteristics and Serological Outcomes of Infants With Confirmed or Suspected Congenital Syphilis in Shanghai, China: A Hospital-Based Study.

Dai Y, Zhai G, Zhang S, Chen C, Li Z, Shi W Front Pediatr. 2022; 10:802071.

PMID: 35281239 PMC: 8904424. DOI: 10.3389/fped.2022.802071.

New screening approach to detecting congenital syphilis in China: a retrospective cohort study.

Hu F, Guo S, Lu J, Hua N, Song Y, Lin S Arch Dis Child. 2020; 106(3):231-237.

PMID: 33355158 PMC: 7907569. DOI: 10.1136/archdischild-2020-320549.

References

Liu Y, Hsiao W, Eggleston K . Equity in health and health care: the Chinese experience. Soc Sci Med. 1999; 49(10):1349-56. DOI: 10.1016/s0277-9536(99)00207-5. View

Heikkinen T, Laine K, Neuvonen P, Ekblad U . The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG. 2000; 107(6):770-5. DOI: 10.1111/j.1471-0528.2000.tb13339.x. View

Wendel Jr G, Sheffield J, Hollier L, Hill J, Ramsey P, Sanchez P . Treatment of syphilis in pregnancy and prevention of congenital syphilis. Clin Infect Dis. 2002; 35(Suppl 2):S200-9. DOI: 10.1086/342108. View

Dayan L, Ooi C . Syphilis treatment: old and new. Expert Opin Pharmacother. 2005; 6(13):2271-80. DOI: 10.1517/14656566.6.13.2271. View

E Pichichero M, Casey J . Safe use of selected cephalosporins in penicillin-allergic patients: a meta-analysis. Otolaryngol Head Neck Surg. 2007; 136(3):340-7. DOI: 10.1016/j.otohns.2006.10.007. View

Douglas Jr J . Penicillin treatment of syphilis: clearing away the shadow on the land. JAMA. 2009; 301(7):769-71. DOI: 10.1001/jama.2009.143. View

. Prevalence of the 23S rRNA A2058G point mutation and molecular subtypes in Treponema pallidum in the United States, 2007 to 2009. Sex Transm Dis. 2012; 39(10):794-8. DOI: 10.1097/OLQ.0b013e31826f36de. View

Barber S, Borowitz M, Bekedam H, Ma J . The hospital of the future in China: China's reform of public hospitals and trends from industrialized countries. Health Policy Plan. 2013; 29(3):367-78. DOI: 10.1093/heapol/czt023. View

Clement M, Okeke N, Hicks C . Treatment of syphilis: a systematic review. JAMA. 2014; 312(18):1905-17. PMC: 6690208. DOI: 10.1001/jama.2014.13259. View

10.

Jiang N, Gong X, Yue X . [Estimation of syphilis epidemic through application of workbook method among populations aged from 15 to 49 years old in China in 2011]. Zhonghua Yu Fang Yi Xue Za Zhi. 2014; 48(8):693-8. View

11.

Gonzalez-Estrada A, Radojicic C . Penicillin allergy: A practical guide for clinicians. Cleve Clin J Med. 2015; 82(5):295-300. DOI: 10.3949/ccjm.82a.14111. View

12.

Newman L, Rowley J, Vander Hoorn S, Wijesooriya N, Unemo M, Low N . Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLoS One. 2015; 10(12):e0143304. PMC: 4672879. DOI: 10.1371/journal.pone.0143304. View

13.

Hook 3rd E . Syphilis and HIV infection. J Infect Dis. 1989; 160(3):530-4. DOI: 10.1093/infdis/160.3.530. View

14.

Dou L, Wang X, Wang F, Wang Q, Qiao Y, Su M . Epidemic Profile of Maternal Syphilis in China in 2013. Biomed Res Int. 2016; 2016:9194805. PMC: 4766319. DOI: 10.1155/2016/9194805. View

15.

Taylor M, Nurse-Findlay S, Zhang X, Hedman L, Kamb M, Broutet N . Estimating Benzathine Penicillin Need for the Treatment of Pregnant Women Diagnosed with Syphilis during Antenatal Care in High-Morbidity Countries. PLoS One. 2016; 11(7):e0159483. PMC: 4951037. DOI: 10.1371/journal.pone.0159483. View

16.

Wijesooriya N, Rochat R, Kamb M, Turlapati P, Temmerman M, Broutet N . Global burden of maternal and congenital syphilis in 2008 and 2012: a health systems modelling study. Lancet Glob Health. 2016; 4(8):e525-33. PMC: 6759483. DOI: 10.1016/S2214-109X(16)30135-8. View

17.

Hook 3rd E . Syphilis. Lancet. 2016; 389(10078):1550-1557. DOI: 10.1016/S0140-6736(16)32411-4. View

18.

Pham M, Ho H, Desai M . Penicillin desensitization: Treatment of syphilis in pregnancy in penicillin-allergic patients. Ann Allergy Asthma Immunol. 2017; 118(5):537-541. DOI: 10.1016/j.anai.2017.03.013. View

19.

Xiao H, Liu D, Li Z, Zheng R, Li Z, Hou J . Comparison of Doxycycline and Benzathine Penicillin G for the Treatment of Early Syphilis. Acta Dermatovenerol Croat. 2017; 25(2):107-111. View

20.

Nurse-Findlay S, Taylor M, Savage M, Mello M, Saliyou S, Lavayen M . Shortages of benzathine penicillin for prevention of mother-to-child transmission of syphilis: An evaluation from multi-country surveys and stakeholder interviews. PLoS Med. 2017; 14(12):e1002473. PMC: 5744908. DOI: 10.1371/journal.pmed.1002473. View